MEMBER LOGIN: Your Email: Password: Remember Me
Forgot Your Password or would like to register?
SYK Stryker Orthopedics
As Of 8/17/2018 7:11:00 PM
Current Price$169.98
Current Rating3
Return Since 9/2015
Stryker Orthopedics72.31 %
S&P 50044.21 %
VFS Rating Analysis
Market ReturnAverage
return vs market
Related Links
Company News
Earnings Call Transcripts
Options Chain
Options Pricing History
For current estimates, historical performance information and more, Log in to your account.

Monthly Performance and Prediction History
Below is the monthly performance history for this security and the monthly change as compared to the stock market for this security. When a row is highlighted in green, it is identifying a stock that the model predict will outperform the portfolio for that month. When a row is highlighted in red, it is identifying a stock that the model predicted will underperform for the month. No highlight indicates the model is neutral on the stock. These predictions are always recorded at the beginning of the month, and table below shows the resulting return for the month.
DateVFS RatingPredictionRating PriceSubsequent
% Increase
Market %
Increase *
7-01-20185 $168.86-3.32%3.70%-7.03%
6-01-20186 $174.02-2.70%0.13%-2.82%
5-01-20184 $169.422.72%2.43%0.28%
4-01-20184 $160.925.28%0.52%4.77%
3-01-20186 $162.16-0.47%-3.13%2.65%
2-01-20188 $164.38-1.35%-3.64%2.29%
* As measured by the performance of the S&P 500 for the month.

SYK25See what the IHS Markit Score report has to say about Stryker Corp. ( 5:02:00 AM
SYK20Market Trends Toward New Normal in ING Group, N.V, Altaba, Steel Dynamics, The TJX Companies, Colgate-Palmolive, and Stryker — Emerging Consolidated Expectations, Analyst Ratings ( 5:15:00 AM
SYK17See what the IHS Markit Score report has to say about Stryker Corp. ( 5:02:00 AM
SYK, MDT15What Does Tandem Diabetes Care’s Valuation Trend Indicate? ( 6:01:00 AM
SYK, MDT15Dentsply Sirona’s Segments: Q2 2018 Performance ( 5:24:00 AM
SYK, MDT15Gauging Dentsply Sirona’s Valuation Trend and Recent Acquisitions ( 5:24:00 AM
SYK15DENTSPLY (XRAY) Beats on Q2 Earnings, Lowers 2018 Guidance ( 7:24:00 AM
SYK15Hologic Expects Robust Earnings Growth for Fiscal 2018 ( 4:33:00 AM
SYK15Hologic Raised Its Revenue Guidance for Fiscal 2018 ( 1:45:00 PM
SYK15Analysts’ Recommendations for Hologic and Its Peers in August ( 12:11:00 PM
SYK15Medical Product Stock Earnings on Aug 6: CAH, HSIC & More ( 9:15:00 AM
SYK15Pacific Biosciences (PACB) Loss In Line With Estimates in Q2 ( 6:58:00 AM
SYK15DexCom (DXCM) Beats Q2 Earnings Estimates, Raises '18 View ( 6:50:00 AM
SYK15Integer Holdings (ITGR) Beats on Q2 Earnings, '18 View Solid ( 5:48:00 AM

WEBSITE DISCLAIMER:  Puget Investors and Vertical Financial Systems, Inc are not registered investment advisers, broker/dealers, or research analysts/organizations. The content on this website is issued solely for information purposes and should not to be construed as an offer to buy, sell, or trade in any way, any security mentioned herein.

All information presented on this website is believed to be reliable and written in good faith, but no representation or warranty, expressed or implied is made as to their accuracy, completeness or correctness. You are responsible for doing your own research before investing in any securities mentioned herein. Readers are urged to consult with their own independent financial advisors with respect to any investment. Neither Vertical Financial Systems, Inc, nor its officers or employees accept any liability whatsoever for any direct or consequential loss arising from any use of information on this website.

Past performance is not a guarantee of future performance or accuracy. Rating calculations and methodology may change at any time, and we reserve the right to make changes which may impact the accuracy of the model without prior notice to anybody.

Be advised that employees and officers of Vertical Financial Systems, Inc and may hold positions in the securities mentioned in this website.
Website Operated by Vertical Financial Systems, Inc